---
title: 'Detecting High-Dose Methotrexate-Induced Brain Changes in Pediatric and Young
  Adult Cancer Survivors Using [<sup>18</sup>F]FDG PET/MRI: A Pilot Study'
date: '2024-04-04'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38575193/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20240405180744&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: 'Significant improvements in treatments for children with cancer have
  resulted in a growing population of childhood cancer survivors who may face long-term
  adverse outcomes. Here, we aimed to diagnose high-dose methotrexate-induced brain
  injury on [^(18)F]FDG PET/MRI and correlate the results with cognitive impairment
  identified by neurocognitive testing in pediatric cancer survivors. Methods: In
  this prospective, single-center pilot study, 10 children and young adults with sarcoma
  (n = ...'
disable_comments: true
---
Significant improvements in treatments for children with cancer have resulted in a growing population of childhood cancer survivors who may face long-term adverse outcomes. Here, we aimed to diagnose high-dose methotrexate-induced brain injury on [^(18)F]FDG PET/MRI and correlate the results with cognitive impairment identified by neurocognitive testing in pediatric cancer survivors. Methods: In this prospective, single-center pilot study, 10 children and young adults with sarcoma (n = ...